ReviewFrontiers in endocrinology2023

Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials?

Giuseppe Fanciulli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.